
|Videos|July 18, 2014
Future Immunotherapy Strategies in Cancer
Advertisement
For High-Definition, Click
The success of immunotherapies will change the way clinical trials are conducted and reported, suggests Louis M. Weiner, MD. Additionally, the success of these agents will set the bar higher for future therapies.
In this segment, panelists discuss their thoughts on future immunotherapy strategies, including treatment strategies that incorporate chimeric antigen receptor therapies, tumor infiltrating lymphocytes, and vaccines.
View the video, to hear the discussion.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5



































